Search

everythinglearnresearchcommunity

for

Search:↓

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Reducing SOX2 in colorectal cancer cells decreases tumor growth and self-renewal.

Some chemotherapy can cause permanent hair loss.

Scalp cooling does not stop hair loss from radiotherapy.

Targeted anticancer therapies often cause skin issues, affecting treatment adherence and quality of life.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Treatments for acute leukaemia lead to high remission rates, but relapses occur, requiring ongoing advancements in care.

EGFR inhibitors for lung cancer can cause severe skin issues.

Alopecia mucinosa on the face can be linked to mycosis fungoides, a type of lymphoma.

Females had more chemotherapy side effects than males, with many being preventable.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Radiation therapy is an effective treatment for severe scalp cellulitis with mild side effects and no long-term complications.

The "Opus-5" diode laser is effective for treating oral submucous fibrosis.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.

Nanoparticle delivery can reduce side effects of the cancer drug doxorubicin.

Oral dutasteride is effective and safe for treating frontal fibrosing alopecia.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

Epidermal growth factor helps hair regrow after chemotherapy.

Lymphoma should be considered in unusual scalp hair loss cases, as treatment can work but may lead to severe complications.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Cetuximab can cause unusual hair growth and hair loss.

More research is needed to confirm initial findings on hair loss patterns from chemotherapy.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.